Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model

NCT03066219 is registered in ClinicalTrials.gov with BRIM Biotechnology Inc. as lead sponsor.

NCT NCT03066219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03066219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Randomized, Double Masked, Placebo Controlled Clinical Study to Assess the Safety and Efficacy of BRM421 Ophthalmic Solution in Subjects With Dry Eye Using a Controlled Adverse Environment (CAE®) Model
Lead sponsor
BRIM Biotechnology Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 7, 2017
Completion date
June 28, 2017
Enrollment
157 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome